Oxurion NV (GB:0G99) has released an update.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Oxurion NV, a Belgian biopharmaceutical company focusing on ophthalmic therapies, has reported a decrease in Atlas Special Opportunities LLC’s shareholding, dropping below the 10% threshold due to a sale of securities. This change in significant holdings was made in compliance with Belgian transparency laws.
For further insights into GB:0G99 stock, check out TipRanks’ Stock Analysis page.